Results 151 to 160 of about 25,089 (208)

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study. [PDF]

Ther Adv Neurol Disord
Oreja-Guevara C, Gómez-Estévez I, Agüado García L, Martín Martínez J, Gómez Gutiérrez M, Gascón Giménez F, Agüera Morales E, Meca-Lallana V, Barrero Hernández FJ, González Quintanilla V, Romero Pinel L, Delgado Gil V, Durán Ferreras E, Blasco Quílez R, Meca-Lallana J, Landete Pascual L, Aladro-Benito Y, Boyero Durán S, Gracia Gil J, Caminero Rodríguez AB, Cano Orgaz AT, Eichau Madueño S, Querol Pascual MR, Otano Martínez M, Alonso Torres AM, Calles Hernández C, López Real A, Ares Luque A, Lorenzo González JR, Gómez Vicente L, Díaz Sánchez M.   +30 more
europepmc   +1 more source

A clinically derived lipid-endothelial signature links serum multi-omics to immune exclusion and clinical stratification in hepatocellular carcinoma. [PDF]

Ther Adv Med Oncol
Yang L, Jin Q, Chen L, Liu Y, Li Y.
europepmc   +1 more source

Pharmacogenetic analyses in people with dementia in Northeast Germany. [PDF]

Alzheimers Dement (Amst)
Meyer-Tönnies MJ, Schwarz L, Wucherer D, Hoffmann W, Thyrian JR, Tzvetkov MV.   +5 more
europepmc   +1 more source

Effect of Cytochrome P450 2C9 genetic polymorphism on agomelatine metabolism <i>in vitro</i>. [PDF]

PeerJ
Fang P, Ni J, Shen T, Chen Q, Ye X, Jin J, Dai D, Hu G, Qian J, Cai J, Chen L.   +10 more
europepmc   +1 more source

Frequency of Key Pharmacogenes CYP2C9, CYP2C19, CYP2D6, and SLCO1B1 in the Yogyakarta Population: Implications for Precision Prescribing in Indonesia. [PDF]

Clin Pharmacol Ther
Nugrahaningsih DAA, Chintyasari S, Wijayaningsih RA, Mustofa, Pratiwi WR, Mayasari DS.   +5 more
europepmc   +1 more source

Induction of cytochrome P450 2C9 and P-glycoprotein activity by antiseizure medications: A systematic review and network meta-analysis. [PDF]

Epileptic Disord
Cohen H, Bahash N, Ben-Shushan T, Matok I, Eyal S.   +4 more
europepmc   +1 more source

Association of decreased CYP2C9 function, <i>HLA-B*40:06</i>, and hemoglobin levels with phenytoin-induced cutaneous adverse reactions in a Southern Thai population. [PDF]

Front Pharmacol
Seree-Aphinan C, Sangiemchoey A, Setthawatcharawanich S, Pattharachayakul S, Hnoonual A, Ruanglertboon W, Intapiboon P, Kaewborisutsakul A, Thamcharoenvipas T, Rachatawiriyakul P, Chongsuvivatwong T, Sittipong S, Sukasem C, Jaruthamsophon K.   +13 more
europepmc   +1 more source

CYP3A-Mediated Metabolism of Zastaprazan in Humans and Associated Drug-Drug Interactions. [PDF]

Pharmaceutics
Cao KJ, Fu L, Sun YC, Meng J, Huang Q, Deng DC, Hu HT, Han ZH, Guo G, Zhou X, Chen XY.   +10 more
europepmc   +1 more source

Generative Artificial Intelligence-Empowered Virtual Evolution of Enzyme with the VERnet Model. [PDF]

ACS Catal
Li C, Xu W, Yang H, Li Y, Zhang L, Chen Z, Wang S, Xie Y, Li H, Liu Y, Li Y, Lu Z, Zhang C, Yu X, Dai D, Jin P, Xiao F.   +16 more
europepmc   +1 more source

Survey to inform personalised prescribing in a British South Asian community: pharmacogenomics and traditional medicine use. [PDF]

BMC Med
Magavern EF, Marengo G, Kanoni S, Patel MG, Spreckley M, Raza M, Khan T, Genes & Health Research Team, Collier D, Caulfield MJ.   +9 more
europepmc   +1 more source